Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Others

Items 161-170 of 318

Page
per page
  1. Tonabersat
    A3883 Tonabersat
    Summary: Gap junction modulator,novel benzopyran compound for Migraine and epilepsy treatment
      Soluble in DMSO
  2. Valspodar
    A3905 Valspodar
    Summary: P-glycoprotein inhibitor
      insoluble in H2O; ≥15.77 mg/mL
  3. Vinorelbine ditartrate
    A3921 Vinorelbine ditartrate
    Summary: Anti-mitotic chemotherapy drug
      ≥33.7 mg/mL
  4. X-NeuNAc
    A3944 X-NeuNAc
    Target: Neuraminidases (NA)
    Summary: Subtrate for chromogeneic assay of neuraminidase activity
      ≥28 mg/mL
  5. Doxycycline hyclate
    A4052 Doxycycline hyclate
    Target: MMP
    Summary: MMP inhibitor
      ≥22.15 mg/mL
  6. Cyclophosphamide monohydrate
    A4232 Cyclophosphamide monohydrate
    Summary: alkylating, cytotoxic agent,antitumor activity
      ≥13.95 mg/mL
  7. 7-Methoxycoumarin-4-acetyl-P-L-G-L-β-(2,4-dinitrophenylamino)A-R amide
    A1500 7-Methoxycoumarin-4-acetyl-P-L-G-L-β-(2,4-dinitrophenylamino)A-R amide
    Summary: Substrate of matrix metalloproteinases assay
      ≥48.7 mg/mL
      insoluble in H2O
  8. Mca-Pro-Leu-NH2
    A1501 Mca-Pro-Leu-NH2
    Summary: Substrate of matrix metalloproteinases assay
  9. Ansamitocin P-3
    A3183 Ansamitocin P-3
    Target: Microtubules/Tubulins
    Summary: Inhibitor of tublin spiralization,maytansine analog
      ≥31.75 mg/mL
  10. Benfotiamine
    A3236 Benfotiamine
    Summary: Drug for painful nerve condition
      insoluble in H2O; insoluble in EtOH; insoluble in DMSO

Items 161-170 of 318

Page
per page
Relate Categories
Specificity
  1. Selective 42item
  2. Non-Selective 1 item
Reversibility
  1. Irreversible 1 item
Target
  1. MMP 1 item
  2. Voltage-gated Potassium (KV) Channels 1 item
  3. Farnesoid X receptors (FXRs) 1 item
  4. P-glycoprotein (P-gp) 1 item
  5. Neuraminidases (NA) 1 item
  6. RARs 1 item
  7. Microtubules/Tubulins 1 item
  8. AMPK 1 item
  9. eIF4E/eIF3G interaction 1 item
  10. Topoisomerases 1 item
  11. Cytochrome P450 (CYP450) 1 item
  12. Toll-like receptors (TLRs) 1 item
  13. BMI-1 1 item
  14. MLK3 1 item
  15. Protease-Activated Receptors 1 item
  16. Calcium chelator 1 item
  17. Dehydrogenase 1 item
  18. BCPCF efflux 1 item
  19. D1 and D5 Receptors 1 item
  20. D2 Receptors 1 item
  21. D3 Receptors 1 item
  22. Angiotensin-Converting Enzymes (ACEs) 1 item
  23. Autophagy 1 item
  24. COX 1 item
  25. C5a receptors 1 item
  26. YAP 1 item
  27. eIF4F 1 item
  28. Glutaminases 2item
  29. Carbonic Anhydrases 3item
  30. BLM 1 item
  31. NADPH Oxidases 1 item
  32. TAK1 1 item
  33. Histamine H1 Receptors 1 item
  34. DYRK 1 item
  35. Ionophores 1 item
  36. MNK 1 item
  37. eEF-2 1 item
  38. Inward Rectifier Potassium (Kir) Channels 1 item
  39. fibrinolysis 1 item
  40. D4 Receptors 1 item
  41. Aldosterone receptor 1 item
  42. Hydroxylases 1 item
  43. Antioxidants 2item
  44. ATGL 1 item
  45. AChR 1 item
  46. calcium uptake 1 item
  47. haspin kinase 1 item
  48. STK 1 item
  49. GABA receptors 1 item
  50. Vitamin D receptors (VDRs) 1 item
  51. Pregnane X receptor(PXR) 1 item
  52. ICAM 1 item
  53. sodium chloride cotransporter 1 item
  54. DprE 1 item
  55. Histone Methyltransferase 1 item
Reported Experiments
  1. Animal Experiments 56item
  2. Cell Experiments 52item
Related Disease
  1. Acute Myeloid Leukemia 2item
  2. Bladder Cancer 1 item
  3. Brain Injuries Studies 1 item
  4. Breast Cancer 4item
  5. Cancer 17item
  6. Colon Cancer 2item
  7. Colorectal Cancer 2item
  8. Dyslipidemia 1 item
  9. Glioblastoma 1 item
  10. Glioma 1 item
  11. HIV 2item
  12. Inflammatory Diseases 4item
  13. Lung Cancer 3item
  14. Lymphoma 2item
  15. Osteoporosis 1 item
  16. Pancreatic Cancer 1 item
  17. Schizophrenia 1 item
  18. Tuberculosis 1 item